Showing results (11-20 of 8,127) with videos related to
Sort By:
Pageof 813
Molecular Pharmaceutics|May 5, 2017
Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle CarrierYi Gou, Yao Zhang, Zhenlei Zhang, et al.Journal of Medicinal Chemistry|May 17, 2021
Developing a Novel Anticancer Gold(III) Agent to Integrate Chemotherapy and ImmunotherapyJuzheng Zhang, Ming Jiang, Shanhe Li, et al.Chemical Biology & Drug Design|May 12, 2015
Structural basis of non-steroidal anti-inflammatory drug diclofenac binding to human serum albuminYao Zhang, Philbert Lee, Shichu Liang, et al.Dalton Transactions (Cambridge, England : 2003)|March 14, 2022
Design of a novel Pt(II) complex to reverse cisplatin-induced resistance in lung cancer via a multi-mechanismMing Jiang, Tongfu Yang, Yong Chu, et al.Journal of Pharmaceutical Sciences|October 31, 2012
Regulation of amantadine hydrochloride binding with IIA subdomain of human serum albumin by fatty acid chainsFeng Yang, Philbert Lee, Zhiyuan Ma, et al.Molecular Pharmaceutics|September 27, 2012
Interactive associations of drug-drug and drug-drug-drug with IIA subdomain of human serum albuminFeng Yang, Jiping Yue, Li Ma, et al.Journal of Medicinal Chemistry|June 12, 2025
Development of a High-Efficacy and Low-Toxicity Cobalt(II) Agent for Targeting Inhibition of Tumor Growth through Mitochondrial Damage-Mediated Chemotherapy and ImmunotherapyMinghui Zhu, Shihang Xu, Guochao Li, et al.European Journal of Medicinal Chemistry|April 23, 2015
Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanismJinxu Qi, Shichu Liang, Yi Gou, et al.Journal of Medicinal Chemistry|December 22, 2022
Developing a Gallium(III) Agent Based on the Properties of the Tumor Microenvironment and Lactoferrin: Achieving Two-Agent Co-delivery and Multi-targeted Combination Therapy of CancerTongfu Yang, Zhenlei Zhang, Juzheng Zhang, et al.Journal of Medicinal Chemistry|June 15, 2023
Developing a Multitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue in the IIA Subdomain of Human Serum AlbuminWenjuan Li, Shanhe Li, Zhenlei Zhang, et al.Pageof 813